Helix BioPharma Corp. announced a private placement financing of 16,655,557 common shares at a price of CAD 0.18 per common share for proceeds of CAD 2,998,000 on August 15, 2023. The common shares issued pursuant are subject to a statutory hold period of four months and one day ending on December 16, 2023, in accordance with applicable securities law.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 CAD | -8.70% | -8.70% | 0.00% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 35.41M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- HBP Stock
- News Helix BioPharma Corp.
- Helix BioPharma Corp. announced that it expects to receive CAD 2.998 million in funding